NewEdge Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.7K | Sell |
94
-34
| -27% | -$8.2K | ﹤0.01% | 2912 |
|
|
2025
Q1 | $31.2K | Sell |
128
-34
| -21% | -$8.28K | ﹤0.01% | 2707 |
|
|
2024
Q4 | $53.2K | Buy |
162
+5
| +3% | +$1.64K | ﹤0.01% | 2506 |
|
|
2024
Q3 | $52.5K | Sell |
157
-49
| -24% | -$16.4K | ﹤0.01% | 2416 |
|
|
2024
Q2 | $56.3K | Sell |
206
-325
| -61% | -$88.8K | ﹤0.01% | 2304 |
|
|
2024
Q1 | $184K | Sell |
531
-155
| -23% | -$53.6K | ﹤0.01% | 1870 |
|
|
2023
Q4 | $222K | Sell |
686
-3
| -0.4% | -$969 | ﹤0.01% | 1670 |
|
|
2023
Q3 | $247K | Sell |
689
-2,396
| -78% | -$859K | ﹤0.01% | 1526 |
|
|
2023
Q2 | $1.17M | Buy |
3,085
+354
| +13% | +$134K | 0.01% | 795 |
|
|
2023
Q1 | $1.31M | Buy |
2,731
+191
| +8% | +$91.5K | 0.02% | 686 |
|
|
2022
Q4 | $73.3K | Buy |
+2,540
| New | +$73.3K | ﹤0.01% | 1571 |
|
|
2022
Q1 | – | Sell |
-272
| Closed | -$206K | – | 1195 |
|
|
2021
Q4 | $206K | Sell |
272
-1,341
| -83% | -$1.02M | ﹤0.01% | 1510 |
|
|
2021
Q3 | $1.2M | Buy |
+1,613
| New | +$1.2M | 0.03% | 460 |
|
|
2021
Q1 | – | Sell |
-1,054
| Closed | -$614K | – | 1034 |
|
|
2020
Q4 | $614K | Buy |
1,054
+167
| +19% | +$97.3K | 0.02% | 554 |
|
|
2020
Q3 | $457K | Buy |
+887
| New | +$457K | 0.02% | 605 |
|